NCT02726984

Brief Summary

Carotid plaque can lead to ischemic stroke. Treatment of asymptomatic carotid plaque, based on degree stenosis, is still controversial. Beyond the degree of stenosis, the composition of the plaque could reflect the vulnerability and the risk of ipsilateral ischemic stroke. Identification of new predictive factor of ipsilateral ischemic stroke in patients with carotid plaque could help to screen high risk patients and to guide the treatment. The aim of the study is to assess 18F-sodium fluoride uptake among carotid plaque in recently symptomatic and asymptomatic patients. Investigators conduct a pilot case-control study. Twelve patients (6 recently symptomatic and 6 asymptomatic) with carotid stenosis (≥50% NASCET) will have a 18F-sodium fluoride PET/MR. Standardized uptake value (SUV) and tissue-to-background ratio (TBR) will be measured among carotid plaques.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2015

Completed
1 month until next milestone

Study Start

First participant enrolled

January 15, 2016

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 4, 2016

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2017

Completed
Last Updated

September 4, 2025

Status Verified

August 1, 2025

Enrollment Period

1.9 years

First QC Date

December 15, 2015

Last Update Submit

August 27, 2025

Conditions

Keywords

strokecarotid plaque18F-sodium fluoride PET/MR

Outcome Measures

Primary Outcomes (4)

  • Measure of SUV (standardized uptake value) among carotid plaques ≥ 50%

    during the last 15 days in symptomatic patients

  • Measure of TBR (tissue-to-background ratio) among carotid plaques ≥ 50%

    at day 0 in asymptomatic patients

  • Measure of SUV (standardized uptake value) among carotid plaques ≥ 50%

    at day 0 in asymptomatic patients

  • Measure of TBR (tissue-to-background ratio) among carotid plaques ≥ 50%

    during the last 15 days in symptomatic patients

Secondary Outcomes (10)

  • Number of participants with image of lipid-rich necrotic core accounting for more than 50% of the surface of the plate on a 2D section.

    during the last 15 days in symptomatic patients

  • Number of participants with image of intraplaque hemorrhage defined as an hyperintense region within the plaque on T1-weighted sequence.

    during the last 15 days in symptomatic patients

  • Number of participants with image of thinning/rupture of the fibrous cap on a T1-weighted sequence following intravenous gadolinium administration.

    during the last 15 days in symptomatic patients

  • Number of participants with image of lipid-rich necrotic core accounting for more than 50% of the surface of the plate on a 2D section.

    at day 0 in asymptomatic patients

  • Number of participants with image of thinning/rupture of the fibrous cap on a T1-weighted sequence following intravenous gadolinium administration.

    at day 0 in asymptomatic patients

  • +5 more secondary outcomes

Study Arms (2)

case

EXPERIMENTAL

Patients with carotid plaque ≥ 50% symptomatic (ischemic stroke on CT or MR) during the last 15 days

Drug: 18F-sodium fluoride PET/MR

control

EXPERIMENTAL

Patients with asymptomatic carotid plaque ≥ 50%

Drug: 18F-sodium fluoride PET/MR

Interventions

18F-sodium fluoride PET/MR combining 3Tesla (3T) MR and PET producing 127 slices of 2 mm on an axial field of view of 26 cm. 18F-sodium fluoride (2 à 4 megabecquerel/kilogram (MBq/kg)) will be injected 60 min before.

casecontrol

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age\>18
  • Carotid plaque ≥ 50% symptomatic (ischemic stroke on CT or MR) during the last 15 days or asymptomatic
  • ability to give informed consent
  • affiliation to social security

You may not qualify if:

  • Modified Rankin score ˃ 3
  • Contraindication to MRI
  • Renal failure (creatinine clearance by cockcroft ˂ 50 ml / min)
  • Pregnancy / Breastfeeding
  • Hypersensitivity to the active substance or excipients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon

Bron, 69500, France

Location

Related Publications (1)

  • Mechtouff L, Sigovan M, Douek P, Costes N, Le Bars D, Mansuy A, Haesebaert J, Bani-Sadr A, Tordo J, Feugier P, Millon A, Luong S, Si-Mohamed S, Collet-Benzaquen D, Canet-Soulas E, Bochaton T, Crola Da Silva C, Paccalet A, Magne D, Berthezene Y, Nighoghossian N. Simultaneous assessment of microcalcifications and morphological criteria of vulnerability in carotid artery plaque using hybrid 18F-NaF PET/MRI. J Nucl Cardiol. 2022 Jun;29(3):1064-1074. doi: 10.1007/s12350-020-02400-0. Epub 2020 Nov 3.

MeSH Terms

Conditions

Carotid StenosisStroke

Condition Hierarchy (Ancestors)

Carotid Artery DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Norbert NIGHOGHOSSIAN, Pr

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2015

First Posted

April 4, 2016

Study Start

January 15, 2016

Primary Completion

December 12, 2017

Study Completion

December 12, 2017

Last Updated

September 4, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations